VOLIBO R 0.2/0.5MG TAB — Uses, Dosage & Benefits

Voglibose 0.2 mg + Repaglinide 0.5 mg tablet

Voglibose is an alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption in the intestine, reducing post-meal glucose spikes. Repaglinide is a short-acting insulin secretagogue (meglitinide) that stimulates pancreatic insulin release, mainly around meals, thereby lowering postprandial blood glucose.

Oral tablet. Take exactly as prescribed. Typically taken before meals (repaglinide is usually taken 15–30 minutes before each main meal; skip the dose if you skip a meal). Voglibose is usually taken just before/with the first bite of meal. Follow your doctor’s instructions for this fixed-dose combination; monitor blood glucose regularly.

Always follow your doctor's prescription. Do not self-medicate.